The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
USP7 - a crucial regulator of cancer hallmarks
Abstract
Over the course of three decades of study, the deubiquitinase Herpesvirus associated Ubiquitin-Specific Protease/Ubiquitin-Specific Protease 7 (HAUSP/USP7) has gradually come to be recognized as a crucially important molecule in cellular physiology. The fact that USP7 is overexpressed in a number of cancers, including breast, prostate, colorectal, and lung cancers, supports the idea that USP7 is also an important regulator of tumorigenesis. In this review, we discuss USP7's function in relation to the cancer hallmarks described by Hanahan and Weinberg. This post-translational modifier can support increased proliferation, block unfavorable growth signals, stop cell death, and support an unstable cellular genome by manipulating key players in the pertinent signalling circuit. It is interesting to note that USP7 also aids in the stabilization of molecules that support angiogenesis and metastasis. Targeting USP7 has now emerged as a crucial component of USP7 research because pharmacological inhibition of USP7 supports p53-mediated cell cycle arrest and apoptosis. Efficacious USP7 inhibition is currently being investigated in both synthetic and natural compounds, but issues with selectivity and a lack of co-crystal structure have hindered USP7 inhibition from being tested in clinical settings. Moreover, the development of new, more effective USP7 inhibitors and their encouraging implications by numerous groups give us a glimmer of hope for USP7-targeting medications as effective substitutes for hazardous cancer chemotherapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a post-translational modifier, USP7 controls cellular pathways that promote cancer progression, including increased proliferation, evasion of growth-suppressive signals, inhibition of apoptosis, and maintenance of genomic instability.49”
From USP7 protects TFEB from proteasome-mediated degradation (2024) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Mathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798
Inflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184
p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086
Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Interaction of Human DNA Polymerase η with Monoubiquitinated PCNA
Kannouche, P. L., Wing, J., & Lehmann, A. R. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00259-x · Cited by 845
Rapid Destruction of Human Cdc25A in Response to DNA Damage
Mailand, N., Falck, J., Lukas, C., Syljuåsen, R. G., Welcker, M., Bartek, J., & Lukas, J. (2000) · Science · doi:10.1126/science.288.5470.1425 · Cited by 787
Acetylation of the p53 DNA-binding domain regulates apoptosis induction.
Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., & McMahon, S. B. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.026 · Cited by 752
Research works printed but not linked: 190
- Hanahan, 2000, The hallmarks of cancer, Cell., 100, 57, 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
- Hanahan, 2011, Hallmarks of cancer: the next generation, Cell., 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
- van der Knaap, 2005, GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7, Mol. Cell, 17, 695, 10.1016/j.molcel.2005.02.013 · DOI · Paper page
- Lu, 2021, Targeting ubiquitin-specific protease 7 (USP7) in cancer: a new insight to overcome drug resistance, Front. Pharmacol., 12
- Yeasmin Khusbu, 2018, Targeting ubiquitin specific protease 7 in cancer: a deubiquitinase with great prospects, Cell Biochem. Funct., 36, 244, 10.1002/cbf.3336 · DOI
- Faesen, 2011, Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase, Mol. Cell, 44, 147, 10.1016/j.molcel.2011.06.034 · DOI · Paper page
- Su, 2018, Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis, J. Clin. Invest., 128, 4280, 10.1172/JCI120518 · DOI
- Cilloni, 2012, Molecular pathways: BCR-ABL, Clin. Cancer Res., 18, 930, 10.1158/1078-0432.CCR-10-1613 · DOI · Paper page
- Elias, 2014, BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-frequency and clinical outcome, Leuk. Res., 38, 454, 10.1016/j.leukres.2013.12.025 · DOI
- Morotti, 2015, HAUSP compartmentalization in chronic myeloid leukemia, Eur. J. Haematol., 94, 318, 10.1111/ejh.12422 · DOI
- Morotti, 2014, BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP, Leukemia., 28, 1326, 10.1038/leu.2013.370 · DOI
- Shibata, 2020, Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells, Oncogene., 39, 3867, 10.1038/s41388-020-1253-0 · DOI
- Huang, 2017, Oridonin triggers chaperon-mediated proteasomal degradation of BCR-ABL in Leukemia, Sci. Rep., 7, 41525, 10.1038/srep41525 · DOI
- Yoshihara, 2012, Insulin/insulin-like growth factor (IGF) stimulation abrogates an association between a deubiquitinating enzyme USP7 and insulin receptor substrates (IRSs) followed by proteasomal degradation of IRSs, Biochem. Biophys. Res. Commun., 423, 122, 10.1016/j.bbrc.2012.05.093 · DOI
- Jones, 1995, Insulin-like growth factors and their binding proteins: biological actions, Endocr. Rev., 16, 3
- Chen, 2015, The deubiquitinating enzyme USP7 regulates androgen receptor activity by modulating its binding to chromatin, J. Biol. Chem., 290, 21713, 10.1074/jbc.M114.628255 · DOI
- Pluciennik, 2021, Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy, J. Clin. Invest., 131, 10.1172/JCI134565 · DOI
- Cartel, 2021, Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy, Leukemia., 35, 417, 10.1038/s41375-020-0878-x · DOI
- Zhang, 2014, ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1, Nat. Cell Biol., 16, 864, 10.1038/ncb3013 · DOI · Paper page
- Bassermann, 2008, The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint, Cell., 134, 256, 10.1016/j.cell.2008.05.043 · DOI · Paper page
- Shin, 2020, Combination of inhibitors of USP7 and PLK1 has a strong synergism against paclitaxel resistance, Int. J. Mol. Sci., 21, E8629, 10.3390/ijms21228629 · DOI
- Yim, 2017, Plk1-mediated stabilization of 53BP1 through USP7 regulates centrosome positioning to maintain bipolarity, Oncogene., 36, 966, 10.1038/onc.2016.263 · DOI
- Oh, 2007, Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity, Biochem. Biophys. Res. Commun., 357, 615, 10.1016/j.bbrc.2007.03.193 · DOI
- Georges, 2019, USP7 regulates cytokinesis through FBXO38 and KIF20B, Sci. Rep., 9, 2724, 10.1038/s41598-019-39368-y · DOI
- Ying, 2006, Targeting retinoblastoma protein for degradation by proteasomes, Cell Cycle, 5, 506, 10.4161/cc.5.5.2515 · DOI
- Delston, 2011, p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis, Oncogene., 30, 588, 10.1038/onc.2010.442 · DOI
- Uchida, 2005, Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation, EMBO J., 24, 160, 10.1038/sj.emboj.7600486 · DOI · Paper page
- Bhattacharya, 2014, HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator, FEBS J., 281, 3061, 10.1111/febs.12843 · DOI
- Granieri, 2022, Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitors, Cell Rep., 40, 10.1016/j.celrep.2022.111396 · DOI
- Huang, 2011, Role of deubiquitylase HAUSP in stem cell maintenance, Cell Cycle, 10, 1182, 10.4161/cc.10.8.15260 · DOI
- Nicklas, 2019, A complex of the ubiquitin ligase TRIM32 and the deubiquitinase USP7 balances the level of c-Myc ubiquitination and thereby determines neural stem cell fate specification, Cell Death Differ., 26, 728, 10.1038/s41418-018-0144-1 · DOI
- Hillje, 2011, Neural stem cells maintain their stemness through protein kinase C ζ-mediated inhibition of TRIM32, Stem Cells, 29, 1437, 10.1002/stem.687 · DOI
- Bhattacharya, 2015, HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP, Cell Oncol (Dordr), 38, 265, 10.1007/s13402-015-0228-6 · DOI
- Welcker, 2004, The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation, Proc. Natl. Acad. Sci. U. S. A., 101, 9085, 10.1073/pnas.0402770101 · DOI · Paper page
- Brockmann, 2016, Small molecule inhibitors of Aurora-a induce proteasomal degradation of N-Myc in childhood neuroblastoma, Cancer Cell, 30, 357, 10.1016/j.ccell.2016.07.002 · DOI
- Otto, 2009, Stabilization of N-Myc is a critical function of Aurora a in human neuroblastoma, Cancer Cell, 15, 67, 10.1016/j.ccr.2008.12.005 · DOI · Paper page
- Tavana, 2016, HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma, Nat. Med., 22, 1180, 10.1038/nm.4180 · DOI · Paper page
- Carrà, 2017, Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones, Oncotarget., 8, 35508, 10.18632/oncotarget.16348 · DOI
- Zou, 2015, miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation, Oncotarget., 6, 1276, 10.18632/oncotarget.2626 · DOI
- Lebrun, 2012, The dual role of TGFβ in human cancer: from tumor suppression to cancer metastasis, ISRN Mol. Biol., 2012
- Huang, 2021, USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer, Cell Death Dis., 12, 880, 10.1038/s41419-021-04176-8 · DOI
- Rodriguez, 2018, PHD3 regulates p53 protein stability by Hydroxylating Proline 359, Cell Rep., 24, 1316, 10.1016/j.celrep.2018.06.108 · DOI
- Tang, 2006, Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis, Mol. Cell, 24, 827, 10.1016/j.molcel.2006.11.021 · DOI · Paper page
- Kim, 2011, DNA damage-induced RORα is crucial for p53 stabilization and increased apoptosis, Mol. Cell, 44, 797, 10.1016/j.molcel.2011.09.023 · DOI
- Zhao, 2003, Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis, Cancer., 98, 18, 10.1002/cncr.11482 · doi:10.1002/cncr.11482
- Dihge, 2008, Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer, Breast Cancer Res. Treat., 109, 255, 10.1007/s10549-007-9645-1 · doi:10.1007/s10549-007-9645-1
- Yi, 2013, SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization, Genes Dev., 27, 274, 10.1101/gad.203760.112 · DOI
- Levine, 2008, Autophagy in the pathogenesis of disease, Cell., 132, 27, 10.1016/j.cell.2007.12.018 · DOI · Paper page
- Mizushima, 2007, Autophagy: process and function, Genes Dev., 21, 2861, 10.1101/gad.1599207 · DOI · Paper page
- Zhang, 2020, USP7 regulates ALS-associated proteotoxicity and quality control through the NEDD4L-SMAD pathway, Proc. Natl. Acad. Sci. U. S. A., 117, 28114, 10.1073/pnas.2014349117 · DOI · Paper page
- Xia, 2020, NEK2 induces autophagy-mediated bortezomib resistance by stabilizing Beclin-1 in multiple myeloma, Mol. Oncol., 14, 763, 10.1002/1878-0261.12641 · DOI
- Fan, 2013, USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis, Cell Death Dis., 4, 10.1038/cddis.2013.400 · DOI · Paper page
- White, 2009, The double-edged sword of autophagy modulation in cancer, Clin. Cancer Res., 15, 5308, 10.1158/1078-0432.CCR-07-5023 · DOI · Paper page
- Lu, 2008, The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells, J. Clin. Invest., 118, 3917
- Bernadotte, 2016, Markers of cellular senescence. Telomere shortening as a marker of cellular senescence, Aging (Albany NY), 8, 3, 10.18632/aging.100871 · DOI · Paper page
- Zemp, 2014, The shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7, J. Biol. Chem., 289, 28595, 10.1074/jbc.M114.596056 · DOI
- Claude, 2019, Specific death of ALT cells through TSPYL5 depletion, Mol. Cell. Oncol., 6
- Lu, 2010, Hypoxia and hypoxia-inducible factors: master regulators of metastasis, Clin. Cancer Res., 16, 5928, 10.1158/1078-0432.CCR-10-1360 · DOI · Paper page
- Olive, 2009, Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science., 324, 1457, 10.1126/science.1171362 · DOI · Paper page
- Zee, 2010, Imaging angiogenesis of genitourinary tumors, Nat. Rev. Urol., 7, 69, 10.1038/nrurol.2009.262 · DOI
- Baeriswyl, 2009, The angiogenic switch in carcinogenesis, Semin. Cancer Biol., 19, 329, 10.1016/j.semcancer.2009.05.003 · DOI · Paper page
- Wu, 2022, Organ defects of the Usp7K444R mutant mouse strain indicate the essential role of K63-polyubiquitinated Usp7 in organ formation, Biom. J., S2319-4170
- Li, 2021, Lnc-RP11-536K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids, J. Exp. Clin. Cancer Res., 40, 348, 10.1186/s13046-021-02143-x · doi:10.1186/s13046-021-02143-x
- Liu, 2015, Hypoxia-inducible factor-1α and Wnt/β-catenin signaling pathways promote the invasion of hypoxic gastric cancer cells, Mol. Med. Rep., 12, 3365, 10.3892/mmr.2015.3812 · DOI
- Liu, 2021, HIF-1-regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation, Proc. Natl. Acad. Sci. U. S. A., 118, 10.1073/pnas.2109144118 · DOI
- Novellasdemunt, 2017, USP7 is a tumor-specific WNT activator for APC-mutated colorectal cancer by mediating β-catenin Deubiquitination, Cell Rep., 21, 612, 10.1016/j.celrep.2017.09.072 · DOI · Paper page
- Lu, 2010, Regulation of tumor angiogenesis by EZH2, Cancer Cell, 18, 185, 10.1016/j.ccr.2010.06.016 · DOI · Paper page
- Lee, 2020, USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells, Genet. Mol. Biol., 43, 10.1590/1678-4685-gmb-2019-0338 · DOI
- Li, 2021, Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis, Mol. Ther. Oncolytics, 20, 583, 10.1016/j.omto.2020.12.008 · DOI
- Ebos, 2009, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, 15, 232, 10.1016/j.ccr.2009.01.021 · DOI · Paper page
- Pàez-Ribes, 2009, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis, Cancer Cell, 15, 220, 10.1016/j.ccr.2009.01.027 · DOI · Paper page
- Yilmaz, 2009, EMT, the cytoskeleton, and cancer cell invasion, Cancer Metastasis Rev., 28, 15, 10.1007/s10555-008-9169-0 · DOI · Paper page
- Dihlmann, 2005, Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics, Int. J. Cancer, 113, 515, 10.1002/ijc.20609 · DOI · Paper page
- Han, 2012, MicroRNA-21 expression is regulated by β-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK, CNS Neurosci. Ther., 18, 573, 10.1111/j.1755-5949.2012.00344.x · DOI
- Basu, 2022, Ubiquitination and deubiquitination in the regulation of epithelial-mesenchymal transition in cancer: shifting gears at the molecular level. Biochimica et Biophysica Acta (BBA) - molecular, Cell Res., 1869
- Zhang, 2016, Expression of USP7 and MARCH7 is correlated with poor prognosis in epithelial ovarian cancer, Tohoku J. Exp. Med., 239, 165, 10.1620/tjem.239.165 · DOI
- Nathan, 2008, The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X, Traffic., 9, 1130, 10.1111/j.1600-0854.2008.00747.x · DOI · Paper page
- Ma, 2014, The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of β-catenin, Mol. Cell. Biol., 34, 4355, 10.1128/MCB.00731-14 · DOI
- Xiang, 2021, Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo, J. Cell. Mol. Med., 25, 9228, 10.1111/jcmm.16834 · DOI
- An, 2017, USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth, Biochem. Pharmacol., 131, 29, 10.1016/j.bcp.2017.02.011 · DOI
- Zeng, 2019, Ubiquitin-specific protease 7 promotes osteosarcoma cell metastasis by inducing epithelial-mesenchymal transition, Oncol. Rep., 41, 543
- Wang, 2010, The role of notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness, Curr. Drug Targets, 11, 745, 10.2174/138945010791170860 · DOI · Paper page
- Jin, 2019, USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-cell Leukemia, Clin. Cancer Res., 25, 222, 10.1158/1078-0432.CCR-18-1740 · DOI
- Kubaichuk, 2019, Involvement of E3 ligases and Deubiquitinases in the control of HIF-α subunit abundance, Cells., 8, E598, 10.3390/cells8060598 · DOI
- Chen, 2021, Diverse roles of FOXO family members in gastric cancer, World J. Gastrointest. Oncol., 13, 1367, 10.4251/wjgo.v13.i10.1367 · DOI
- Jiramongkol, 2020, FOXO transcription factor family in cancer and metastasis, Cancer Metastasis Rev., 39, 681, 10.1007/s10555-020-09883-w · DOI · Paper page
- Dansen, 2008, Unravelling the tumor-suppressive functions of FOXO proteins, Trends Cell Biol., 18, 421, 10.1016/j.tcb.2008.07.004 · DOI · Paper page
- Kim, 2018, Role of Forkhead box class O proteins in cancer progression and metastasis, Semin. Cancer Biol., 50, 142, 10.1016/j.semcancer.2017.07.007 · DOI
- van der Horst, 2006, FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP, Nat. Cell Biol., 8, 1064, 10.1038/ncb1469 · DOI · Paper page
- Brenkman, 2008, Mdm2 induces mono-ubiquitination of FOXO4, PLoS One, 3, 10.1371/journal.pone.0002819 · DOI
- Wang, 2012, Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation, Oncogene., 31, 1546, 10.1038/onc.2011.347 · DOI · Paper page
- Lei, 2019, EZH2 regulates protein stability via recruiting USP7 to mediate neuronal gene expression in cancer cells, Front. Genet., 10, 422, 10.3389/fgene.2019.00422 · DOI
- Gagarina, 2020, Structural basis of the interaction between ubiquitin specific protease 7 and enhancer of Zeste homolog 2, J. Mol. Biol., 432, 897, 10.1016/j.jmb.2019.12.026 · DOI
- Duan, 2022, EZH2-CCF-cGAS Axis promotes breast cancer metastasis, Int. J. Mol. Sci., 23, 1788, 10.3390/ijms23031788 · DOI
- Wang, 2015, The positive feedback between snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer, Oncotarget., 6, 27427, 10.18632/oncotarget.4861 · DOI
- Tiwari, 2013, Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming, Cancer Cell, 23, 768, 10.1016/j.ccr.2013.04.020 · DOI · Paper page
- Yi, 2016, Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway, Oncol. Rep., 36, 2935, 10.3892/or.2016.5099 · DOI
- 2020, Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer, EMBO Rep., 21
- Tauriello, 2010, The various roles of ubiquitin in Wnt pathway regulation, Cell Cycle, 9, 3700, 10.4161/cc.9.18.13204 · DOI
- Ji, 2019, USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin, Nat. Commun., 10, 4184, 10.1038/s41467-019-12143-3 · DOI
- Jeggo, 2016, DNA repair, genome stability and cancer: a historical perspective, Nat. Rev. Cancer, 16, 35, 10.1038/nrc.2015.4 · DOI · Paper page
- He, 2014, Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis, J. Biol. Chem., 289, 27278, 10.1074/jbc.M114.589812 · DOI
- Coleman, 2011, The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection, J. Biol. Chem., 286, 13669, 10.1074/jbc.M110.213728 · DOI · Paper page
- Hu, 2011, RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci, Genes Dev., 25, 685, 10.1101/gad.2011011 · DOI · Paper page
- Zimmermann, 2013, 53BP1 regulates DSB repair using Rif1 to control 5′ end resection, Science., 339, 700, 10.1126/science.1231573 · DOI · Paper page
- Poulsen, 2012, Human RNF169 is a negative regulator of the ubiquitin-dependent response to DNA double-strand breaks, J. Cell Biol., 197, 189, 10.1083/jcb.201109100 · DOI · Paper page
- Bunting, 2010, 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks, Cell., 141, 243, 10.1016/j.cell.2010.03.012 · DOI · Paper page
- Smith, 2010, The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer, Adv. Cancer Res., 108, 73, 10.1016/B978-0-12-380888-2.00003-0 · DOI · Paper page
- Boiteux, 2013, DNA repair mechanisms and the bypass of DNA damage in Saccharomyces cerevisiae, Genetics., 193, 1025, 10.1534/genetics.112.145219 · DOI · Paper page
- Marians, 2018, Lesion bypass and the reactivation of stalled replication forks, Annu. Rev. Biochem., 87, 217, 10.1146/annurev-biochem-062917-011921 · DOI · Paper page
- Hoege, 2002, RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO, Nature., 419, 135, 10.1038/nature00991 · DOI · Paper page
- Ripley, 2020, Control of DNA damage bypass by Ubiquitylation of PCNA, Genes (Basel), 11, E138, 10.3390/genes11020138 · DOI · Paper page
- Jung, 2012, DNA polymerase eta is targeted by Mdm2 for polyubiquitination and proteasomal degradation in response to ultraviolet irradiation, DNA Repair (Amst), 11, 177, 10.1016/j.dnarep.2011.10.017 · DOI · Paper page
- Schwertman, 2012, UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair, Nat. Genet., 44, 598, 10.1038/ng.2230 · DOI · Paper page
- Fang, 2000, Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53, J. Biol. Chem., 275, 8945, 10.1074/jbc.275.12.8945 · DOI · Paper page
- Stad, 2001, Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms, EMBO Rep., 2, 1029, 10.1093/embo-reports/kve227 · DOI · Paper page
- Tang, 2006, Critical role for Daxx in regulating Mdm2, Nat. Cell Biol., 8, 855, 10.1038/ncb1442 · DOI · Paper page
- Tang, 2010, Daxx is reciprocally regulated by Mdm2 and Hausp, Biochem. Biophys. Res. Commun., 393, 542, 10.1016/j.bbrc.2010.02.051 · DOI
- Song, 2008, The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex, EMBO J., 27, 1863, 10.1038/emboj.2008.115 · DOI
- Zhang, 2014, ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53, Nat. Commun., 5, 5059, 10.1038/ncomms6059 · DOI
- Shen, 2018, TSPY1 suppresses USP7-mediated p53 function and promotes spermatogonial proliferation, Cell Death Dis., 9, 542, 10.1038/s41419-018-0589-7 · DOI
- Macheret, 2015, DNA replication stress as a Hallmark of cancer, Annu. Rev. Pathol.: Mech. Dis., 10, 425, 10.1146/annurev-pathol-012414-040424 · DOI · Paper page
- McGarry, 1998, Geminin, an inhibitor of DNA replication, is degraded during mitosis, Cell., 93, 1043, 10.1016/S0092-8674(00)81209-X · DOI · Paper page
- Lecona, 2016, A SUMO and ubiquitin code coordinates protein traffic at replication factories, Bioessays., 38, 1209, 10.1002/bies.201600129 · DOI
- Franz, 2021, USP7 and VCPFAF1 define the SUMO/ubiquitin landscape at the DNA replication fork, Cell Rep., 37, 10.1016/j.celrep.2021.109819 · DOI
- Ma, 2013, Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells, Immunity., 38, 729, 10.1016/j.immuni.2013.03.003 · DOI · Paper page
- Zhao, 2021, Inflammation and tumor progression: signaling pathways and targeted intervention, Signal Transduct Target Ther., 6, 263, 10.1038/s41392-021-00658-5 · DOI · Paper page
- Hayden, 2008, Shared principles in NF-kappaB signaling, Cell., 132, 344, 10.1016/j.cell.2008.01.020 · DOI · Paper page
- Mao, 2009, GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA, Genes Dev., 23, 849, 10.1101/gad.1748409 · DOI
- Ryo, 2003, Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA, Mol. Cell, 12, 1413, 10.1016/S1097-2765(03)00490-8 · DOI · Paper page
- Tanaka, 2007, PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit, Nat. Immunol., 8, 584, 10.1038/ni1464 · DOI · Paper page
- Maine, 2007, COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase, EMBO J., 26, 436, 10.1038/sj.emboj.7601489 · DOI · Paper page
- Carmody, 2007, Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade, Science., 317, 675, 10.1126/science.1142953 · DOI · Paper page
- Liu, 2017, Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression, Hepatology., 66, 1894, 10.1002/hep.29337 · DOI
- Gan, 2009, HSCARG inhibits activation of NF-kappaB by interacting with IkappaB kinase-beta, J. Cell Sci., 122, 4081, 10.1242/jcs.054007 · DOI
- Li, 2014, HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination, Cell Death Dis., 5, 10.1038/cddis.2014.197 · DOI
- Xia, 2019, Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis, Cancer Lett., 465, 118, 10.1016/j.canlet.2019.09.003 · DOI
- Lee, 2011, Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers, Mol. Cell, 43, 798, 10.1016/j.molcel.2011.08.011 · DOI · Paper page
- Su, 2021, Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis, Nucleic Acids Res., 49, 4421, 10.1093/nar/gkab209 · DOI
- Zhao, 2020, P22077 inhibits LPS-induced inflammatory response by promoting K48-linked ubiquitination and degradation of TRAF6, Aging (Albany NY), 12, 10969, 10.18632/aging.103309 · DOI
- O’Callaghan, 2015, Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer, Eur. Respir. J., 46, 1762, 10.1183/13993003.00176-2014 · DOI
- Tu, 2017, Annexin A1 influences in breast cancer: controversies on contributions to tumour, host and immunoediting processes, Pharmacol. Res., 119, 278, 10.1016/j.phrs.2017.02.011 · DOI
- Powell, 2007, Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo, J. Immunol., 179, 4919, 10.4049/jimmunol.179.7.4919 · DOI · Paper page
- Sharma, 2011, Novel cancer immunotherapy agents with survival benefit: recent successes and next steps, Nat. Rev. Cancer, 11, 805, 10.1038/nrc3153 · DOI · Paper page
- Pardoll, 2012, The blockade of immune checkpoints in cancer immunotherapy, Nat. Rev. Cancer, 12, 252, 10.1038/nrc3239 · DOI · Paper page
- Dranoff, 2005, CTLA-4 blockade: unveiling immune regulation, J. Clin. Oncol., 23, 662, 10.1200/JCO.2005.09.923 · DOI
- Fietta, 2009, Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer, Hum. Immunol., 70, 477, 10.1016/j.humimm.2009.03.012 · DOI
- van Loosdregt, 2013, Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity, Immunity., 39, 259, 10.1016/j.immuni.2013.05.018 · DOI · Paper page
- De Ceuninck, 2013, Reciprocal cross-regulation between RNF41 and USP8 controls cytokine receptor sorting and processing, J. Cell Sci., 126, 3770
- Colombo, 2010, Synthesis and biological evaluation of 9-Oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes, ChemMedChem., 5, 552, 10.1002/cmdc.200900409 · DOI · Paper page
- Kim, 2017, Foxp3 is a key downstream regulator of p53-mediated cellular senescence, Oncogene., 36, 219, 10.1038/onc.2016.193 · DOI
- Wang, 2016, Ubiquitin-specific Protease-7 inhibition impairs Tip60-dependent Foxp3+ T-regulatory cell function and promotes antitumor immunity, EBioMedicine., 13, 99, 10.1016/j.ebiom.2016.10.018 · DOI
- Wang, 2017, Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60, PLoS One, 12, 10.1371/journal.pone.0189744 · DOI
- Khosravi, 2018, Induction of CD4+CD25+FOXP3+ regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation, Stem Cell Res Ther, 9, 273, 10.1186/s13287-018-0991-1 · DOI
- Fu, 2019, Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy, Onco. Targets Ther., 12, 609, 10.2147/OTT.S182806 · DOI
- Yang, 2020, The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation, EMBO Rep., 21, 10.15252/embr.202050308 · DOI
- Muthukumarana, 2006, Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance, Int. Immunopharmacol., 6, 1993, 10.1016/j.intimp.2006.09.015 · DOI
- Wang, 2020, Mouse double minute 2 homolog-mediated ubiquitination facilitates Forkhead box P3 stability and positively modulates human regulatory T cell function, Front. Immunol., 11, 1087, 10.3389/fimmu.2020.01087 · DOI
- Wang, 2021, Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing, Acta Pharm. Sin. B, 11, 694, 10.1016/j.apsb.2020.11.005 · DOI
- Dai, 2020, USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer, Theranostics., 10, 9332, 10.7150/thno.47137 · DOI · Paper page
- Chen, 2021, Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC, Mol. Cancer, 20, 144, 10.1186/s12943-021-01448-x · DOI · Paper page
- Henrique, 2020, Biological and physical approaches on the role of piplartine (piperlongumine) in cancer, Sci. Rep., 10
- Park, 2015, Annexin-1 regulated by HAUSP is essential for UV-induced damage response, Cell Death Dis., 6, 10.1038/cddis.2015.32 · DOI
- Warburg, 1956, On the origin of cancer cells, Science., 123, 309, 10.1126/science.123.3191.309 · DOI · Paper page
- Kim, 2021, Regulation of cancer metabolism by deubiquitinating enzymes: the Warburg effect, Int. J. Mol. Sci., 22, 6173, 10.3390/ijms22126173 · DOI
- Hall, 2014, USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy, Mol. Endocrinol., 28, 912, 10.1210/me.2013-1420 · DOI
- Kiran, 2015, Sirtuin 7 in cell proliferation, stress and disease: rise of the seventh Sirtuin!, Cell. Signal., 27, 673, 10.1016/j.cellsig.2014.11.026 · DOI
- Wu, 2018, Advances in cellular characterization of the Sirtuin isoform, SIRT7, Front. Endocrinol. (Lausanne), 9, 652, 10.3389/fendo.2018.00652 · DOI
- Jiang, 2017, Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis, J. Biol. Chem., 292, 13296, 10.1074/jbc.M117.780130 · DOI
- Georges, 2018, Identification and characterization of USP7 targets in cancer cells, Sci. Rep., 8, 15833, 10.1038/s41598-018-34197-x · DOI
- Felle, 2011, The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1, Nucleic Acids Res., 39, 8355, 10.1093/nar/gkr528 · DOI · Paper page
- Qin, 2011, Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1, J. Cell. Biochem., 112, 439, 10.1002/jcb.22998 · DOI · Paper page
- Jenkins, 2005, Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth, Mol. Biol. Cell, 16, 5621, 10.1091/mbc.e05-03-0194 · DOI · Paper page
- Saha, 2022, USP7 targets XIAP for cancer progression: establishment of a p53-independent therapeutic avenue for glioma, Oncogene, 41, 5061, 10.1038/s41388-022-02486-5 · DOI
- Bushman, 2021, Proteomics-based identification of DUB substrates using selective inhibitors, Cell Chem. Biol., 28, 78, 10.1016/j.chembiol.2020.09.005 · DOI
- Steger, 2021, Time-resolved in vivo ubiquitinome profiling by DIA-MS reveals USP7 targets on a proteome-wide scale, Nat. Commun., 12, 5399, 10.1038/s41467-021-25454-1 · DOI
- Tsukamoto, 2016, Search for inhibitors of the ubiquitin-proteasome system from natural sources for cancer therapy, Chem. Pharm. Bull. (Tokyo), 64, 112, 10.1248/cpb.c15-00768 · DOI
- Li, 2020, Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors, Eur. J. Med. Chem., 191, 10.1016/j.ejmech.2020.112107 · DOI
- Altun, 2011, Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes, Chem. Biol., 18, 1401, 10.1016/j.chembiol.2011.08.018 · DOI · Paper page
- Chen, 2017, Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors, Bioorg. Med. Chem. Lett., 27, 845, 10.1016/j.bmcl.2017.01.018 · DOI
- Colland, 2009, Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells, Mol. Cancer Ther., 8, 2286, 10.1158/1535-7163.MCT-09-0097 · DOI · Paper page
- Ohol, 2020, Novel, selective inhibitors of USP7 uncover multiple mechanisms of antitumor activity in vitro and in vivo, Mol. Cancer Ther., 19, 1970, 10.1158/1535-7163.MCT-20-0184 · DOI
- Li, 2021, Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors, Eur. J. Med. Chem., 216, 10.1016/j.ejmech.2021.113291 · DOI
- Gavory, 2018, Discovery and characterization of highly potent and selective allosteric USP7 inhibitors, Nat. Chem. Biol., 14, 118, 10.1038/nchembio.2528 · DOI · Paper page
- Murgai, 2022, Targeting the deubiquitinase USP7 for degradation with PROTACs, Chem. Commun. (Camb.), 58, 8858, 10.1039/D2CC02094G · DOI
- Pei, 2022, Discovery of a potent and selective degrader for USP7, Angew. Chem. Int. Ed. Eng., 61
- Li, 2020, N-benzylpiperidinol derivatives as novel USP7 inhibitors: structure-activity relationships and X-ray crystallographic studies, Eur. J. Med. Chem., 199, 10.1016/j.ejmech.2020.112279 · DOI
- Yamaguchi, 2013, Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor, Bioorg. Med. Chem. Lett., 23, 3884, 10.1016/j.bmcl.2013.04.066 · DOI
- Tanokashira, 2016, Petroquinones: trimeric and dimeric xestoquinone derivatives isolated from the marine sponge Petrosia alfiani, Tetrahedron., 72, 5530, 10.1016/j.tet.2016.07.045 · DOI
- Afifi, 2017, Sulawesins A–C, Furanosesterterpene Tetronic Acids That Inhibit USP7, from a Psammocinia sp. Marine Sponge, J. Nat. Prod., 80, 2045, 10.1021/acs.jnatprod.7b00184 · DOI
Cited by
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
USP7 protects TFEB from proteasome-mediated degradation
Keshri, S., Vicinanza, M., Takla, M., & Rubinsztein, D. C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114872 · Cited by 13
Metadata
- Authors
- Saha, G., Roy, S., Basu, M., & Ghosh, M. K.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 1878
- Issue
- 3
- Pages
- 188903
- ISSN
- 0304-419X
- Cited by
- 101
- References
- 53
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Department of Science and Technology, Ministry of Science and Technology, India (DST/NM/NT/2018/105)
- Council of Scientific and Industrial Research, India (HCP-40, MLP-142)
- Science and Engineering Research Board (EMR/2017/000992/HS)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: USP7 - a crucial regulator of cancer hallmarks. https://app.cochat.ai/papers/10.1016/j.bbcan.2023.188903
- The paper
- Saha, G., Roy, S., Basu, M., & Ghosh, M. K. (2023). USP7 - a crucial regulator of cancer hallmarks. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2023.188903
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.